Editas Medicine, Inc. short interest in 2026
In 2026, Editas Medicine, Inc.'s disclosed short interest ran from 12.12% of shares outstanding on 15 Jan 2026 to 19.51% on 15 Sep 2026, a change of +7.39 percentage points. The year's high was 22.95% on 30 Jun 2026 and its low 9.77% on 15 May 2026, averaging 14.92% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.19 days on 31 Jul 2026. Full history: Editas Medicine, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 12.12% (15 Jan 2026)
- End of year
- 19.51% (15 Sep 2026)
- Change
- +7.39 pp
- High
- 22.95% (30 Jun 2026)
- Low
- 9.77% (15 May 2026)
- Average
- 14.92%
- Highest days to cover
- 18.19 (31 Jul 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 12.12% | 6.04 | |
| 30 Jan 2026 | 11.74% | 6.11 | |
| 13 Feb 2026 | 12.03% | 7.99 | |
| 27 Feb 2026 | 12.18% | 8.20 | |
| 13 Mar 2026 | 11.80% | 5.07 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 12.23% | 8.62 | |
| 15 Apr 2026 | 11.18% | 6.48 | |
| 30 Apr 2026 | 10.22% | 7.07 | |
| 15 May 2026 | 9.77% | 8.56 | 10-Q filed, results (8-K) |
| 29 May 2026 | 15.39% | 3.36 | |
| 15 Jun 2026 | 18.81% | 7.70 | |
| 30 Jun 2026 | 22.95% | 7.21 | |
| 15 Jul 2026 | 22.67% | 8.02 | |
| 31 Jul 2026 | 15.28% | 18.19 | |
| 14 Aug 2026 | 16.07% | 14.59 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 19.69% | 8.96 | |
| 15 Sep 2026 | 19.51% | 15.72 |
See also: Editas Medicine, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.